Endra Life Sciences Soars 29.17% on Zacks Rank Upgrade

Mover TrackerWednesday, Apr 30, 2025 4:21 am ET

1min read

NDRA --

On April 30, 2025, Endra Life Sciences surged 29.17% in pre-market trading, marking a significant rise in its stock value.

Endra Life Sciences has been upgraded to a Zacks Rank #1 (Strong Buy), indicating a growing optimism about the company's earnings prospects. This upgrade reflects the market's positive outlook on the company's future performance.

Analysts have set a 12-month price target for Endra Life Sciences, predicting a substantial increase from the current stock price. This target suggests that the company is expected to experience significant growth in the coming year.

Comments

Add a public comment...

Post

WeightNeat

04/30

OMG!The NDRA stock was in an easy trading mode with Pro tools, and I made $164 from it!

CopyGrand7281

04/30

@WeightNeat How long were you holding NDRA before selling? Curious about your strategy.

Lukedf9

04/30

@WeightNeat Sold early, bro. Could've been more if held longer. FOMO hitting hard now.

No More Comment

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.

You Can Understand News Better with AI.

Whats the News impact on stock market?

Its impact is

AInvest

Aime Coplilot

Invest Smarter With AI Power.

Open App